Clinuvel Pharmaceuticals (CUV.AU) Q1 2023 Earnings

24FebConfirmed
Q3 2021
Q1 2022
Q3 2022
Q1 2023
0.11
0.19
0.28
0.36

Details

Expected EPS
0.31
Actual EPS
0.22
Surprise EPS
-0.09
Surprise Percent
+29.03%

Description

Clinuvel Pharmaceuticals (CUV.AU) has reported earnings of 0.22 per share for Q1 2023.

0 Comments

Share your thoughts